Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126530401 | 12653040 | 1 | I | 2013 | 20160727 | 20160815 | 20160815 | EXP | PHHY2016FR106303 | SANDOZ | 85.00 | YR | F | Y | 0.00000 | 20160815 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126530401 | 12653040 | 1 | PS | ALPRAZOLAM. | ALPRAZOLAM | 1 | Unknown | 0.25 MG, QD (DAILY DOSE) | 74112 | .25 | MG | QD | |||||||
| 126530401 | 12653040 | 2 | SS | LOPRAZOLAM | LOPRAZOLAM | 1 | Unknown | 1 MG, UNK | 0 | 1 | MG | ||||||||
| 126530401 | 12653040 | 3 | C | PAROXETINE. | PAROXETINE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126530401 | 12653040 | 1 | Product used for unknown indication |
| 126530401 | 12653040 | 2 | Product used for unknown indication |
| 126530401 | 12653040 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126530401 | 12653040 | HO |
| 126530401 | 12653040 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126530401 | 12653040 | Dyspnoea | |
| 126530401 | 12653040 | Seizure | |
| 126530401 | 12653040 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |